BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24577158)

  • 1. Role of elevated cancer antigen 19-9 in women with mature cystic teratoma.
    Frimer M; Seagle BL; Chudnoff S; Goldberg GL; Shahabi S
    Reprod Sci; 2014 Oct; 21(10):1307-11. PubMed ID: 24577158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers in mature cystic teratomas of the ovary.
    Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-stratified analysis of tumor markers and tumor characteristics in adolescents and young women with mature cystic teratoma.
    Yesilyurt H; Seckin B; Aktulay A; Ozyer S
    J Chin Med Assoc; 2018 Jun; 81(6):499-504. PubMed ID: 28826726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
    Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
    Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
    Kataoka T; Watanabe Y; Hoshiai H
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
    Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
    Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
    Cho HY; Kim K; Jeon YT; Kim YB; No JH
    Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of mature cystic teratoma of the greater omentum misdiagnosed as ovarian cyst.
    Yoshida A; Murabayashi N; Shiozaki T; Okugawa T; Tabata T
    J Obstet Gynaecol Res; 2005 Oct; 31(5):399-403. PubMed ID: 16176507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mediastinal mature teratoma perforating into the lung with elevated serum carbohydrate antigen 19-9 (CA19-9) levels; report of a case].
    Kimura C; Kamiyoshihara M; Sakata K; Itoh H; Morishita Y
    Kyobu Geka; 2003 Mar; 56(3):247-50. PubMed ID: 12649920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated CA 19-9 levels in mature cystic teratoma of the ovary.
    Kyung MS; Choi JS; Hong SH; Kim HS
    Int J Biol Markers; 2009; 24(1):52-6. PubMed ID: 19404923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
    Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
    Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
    Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
    Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
    Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent elevation of CA 19-9 levels in a patient with an extended retroperitoneal dermoid.
    Micke O; Schafer U; Willich N
    Anticancer Res; 1999; 19(4A):2717-20. PubMed ID: 10470227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
    Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
    World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant mature ovarian cystic teratoma including more than 300 teeth.
    Devoize L; Collangettes D; Le Bouëdec G; Mishellany F; Orliaguet T; Dallel R; Baudet-Pommel M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):e76-9. PubMed ID: 18280952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.
    Nanki Y; Chiyoda T; Kataoka F; Nomura H; Nakadaira N; Iwasa N; Hashimoto S; Arima H; Susumu N; Aoki D
    J Obstet Gynaecol Res; 2017 Apr; 43(4):744-748. PubMed ID: 28370831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.